A critical gap exists in determining treatment preferences and treatment satisfaction from
patient perspectives, which is paramount to achieving therapeutic success. The objective of …

Background Psoriasis is a debilitating chronic inflammatory autoimmune disease affecting
approximately 7.4 million adults in the United States. Plaque psoriasis is the most common …

Little is known about the drug survival of second-line biologic therapies for psoriasis in
routine clinical practice. We assessed drug survival of second-line biologic therapies and …

Background and objective Adherence to treatment in patients with psoriasis is often poor. An
investigation of patient preferences and satisfaction with treatment may be important, based …

Psoriasis is a chronic and recurrent immune-related skin disease that often causes
disfigurement and disability. Due to the visibility of lesions in patients and inadequate …

Psoriatic arthritis (PsA) is a multifaceted disease, with a high impact on patients'
psychological and physical well-being. There is increasing recognition that assessment of …

Cosmetics have a long history of use for regenerative and therapeutic purposes that are
appealing to both genders. The untapped potential of nanotechnology in cosmeceuticals …

Background/Aims: Circular RNAs (circRNAs) are evolutionary conserved circular non-
coding RNAs that play a role in several diseases by sequestering (sponging) microRNAs …

Background Tofacitinib is an oral Janus kinase inhibitor that improves clinical measures of
psoriasis. Objective We sought to assess patient-reported outcomes in tofacitinib-treated …

The advances in psoriasis management currently allow achieving a good control of the
disease. In particular, with the latest developed molecules, available evidence suggests that …